Accessibility Menu

Danaher(FRA) DAP

Market Cap€131.53BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2000)+1,423%
5 Year-24%
1 Year+5%
1 Month+9%
€184.20
-0.94%
-1.75Today
Danaher last closing stock price
MetricPriceDate
Last closeEUR 183.752026-08-31
Danaher stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-0.51%EUR 184.702026-08-24
1 month+9.02%EUR 168.552026-07-31
3 month+21.09%EUR 151.752026-06-02
Year to date-6.16%EUR 195.822025-12-30
1 year+4.64%EUR 175.602025-08-29
3 year-15.63%EUR 217.792023-09-01
5 year-24.42%EUR 243.132021-09-01
Since inception+1,422.76%EUR 12.212000-10-10

Danaher Financials at a Glance

Market Cap

€131.53BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

€21.53K

Net Income (TTM)

€3.42K

EPS (TTM)

€4.83

P/E Ratio

38.74

Dividend

€1.24

Beta (Volatility)

-0.02 (Low)

Price

€184.20

Volume

780

Open

€185.50

Previous Close

€184.20

Daily Range

€183.70 - €185.80

52-Week Range

€137.80 - €208.30

Estimated Earnings Date

N/A

DAP News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Danaher

Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments: Biotechnology, Life Sciences, Diagnostics, and Environmental and Applied Solutions. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a range of tools, consumables, and services. The Life Sciences segment offers a range of instruments and consumables to study the basic building blocks of life, including DNA and RNA. The Diagnostics segment offers clinical instruments, reagents, consumables, software, and services used to diagnose disease and make treatment decisions. The Environmental and Applied Solution segment offers products and services that help protect important resources and keep global food and water supplies safe. The company was founded by Steven M. Rales and Mitchell P. Rales in 1984 and is headquartered in Washington, DC.

Industry

Life Sciences Tools and Services

Sector

Health Care

Employees

60,000

CEO

Rainer M. Blair

Website

www.danaher.com

DAP Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

7.55%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

2.58%

Dividend Yield

0.66%

Payout Ratio

N/A

Stock Overview

Market Cap

€131.53BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

702.99M

Volume

780

Avg. Volume

410.712

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Danaher Performance Analysis

Danaher annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31EUR 25,350,762,2201.7%
20232023-12-31EUR 22,097,544,364-12.8%
20242024-12-31EUR 22,071,927,545-0.1%
20252025-12-31EUR 21,768,988,121-1.4%
Danaher annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31EUR 9.1725.8%
20232023-12-31EUR 5.90-35.6%
20242024-12-31EUR 4.89-17.2%
20252025-12-31EUR 4.47-8.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

€5.39K

+1.0%

Gross Profit

€3.11K

+0.9%

Gross Margin

57.64%

+0.9%

Market Cap

€131.53BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

€1.97

N/A

Employees

60,000

N/A

Net Income

€748.25

+1.5%

EBITDA

€1.59K

+1.0%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

€28.17K

+53.7%

Total Debt

€24.37K

+1.5%

Accounts Receivable

€3.47K

+1.1%

Inventory

€2.85K

+1.2%

Long Term Debt

€22.00K

+1.5%

Short Term Debt

€2.37K

+1.6%

Return on Assets

4.55%

+1.0%

Return on Invested Capital

7.01%

+1.0%

Free Cash Flow

€1.09K

+1.2%

Operating Cash Flow

€1.33K

+1.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,684.24-0.00%
^DJIDJI
$53,254.61-0.01%
^IXICNASDAQ
$26,319.55-0.00%
BTCBitcoin
$78,890.00-0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$13.27-0.20%
NVDANvidia
$220.78+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.97+0.11%
CNHCNH Industrial
$11.83+0.01%

Questions About DAP

What is the current price of Danaher?

Danaher is trading at €184.20 per share.

What is the 52-week range for Danaher?

Over the past 52 weeks, Danaher has traded between €137.80 and €208.30.

How much debt does Danaher have?

As of the most recent reporting period, Danaher reported total debt of €24.37B.

How much cash does Danaher have on hand?

Danaher reported €3.80B in cash and cash equivalents in its most recent financial results.

What is Danaher’s dividend yield?

Danaher currently has a dividend yield of 0.66%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services